INCY

#506
Incyte Genomics Inc
101.27
+3.23%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
101.27
101.27
Jahresspanne
53.56
112.29
Tagesänderung
+3.23%
Monatliche Änderung
-1.70%
6 month change
+19.86%
Jahresänderung
+37.73%
Vorheriger Schlusskurs
98.10
Open
101.27
Bid
Ask
Low
101.27
High
101.27
Volumen
241
Open full chart

Financials

Overview Finanzbericht Statistics Dividends
Quarterly Annual
  • Market Capitalization 19.77 B
  • Employee 2 844
  • Founded 2002
  • CEO Hervé Hoppenot
  • Website www.incyte.com
  • Headquarter Delaware, United States
  • FIGI BBG000BNPSQ9
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
15.41
Price to sales ratio
3.86
Dividends per share
—
Dividend yield %
—

Incyte Corporation

Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia. Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity.

Nachrichten